Skip to main content

Table 1 Baseline characteristics of the study group with IgAN

From: Vitamin D deficiency may predict a poorer outcome of IgA nephropathy

  Total (n = 105)
Age (year) 34.73 ± 12.19
Male (n/%) 57(54.3 %)
Smoker (n/%) 32(30.5 %)
Body mass index (kg/m2) 23.2 ± 3.18
Systolic blood pressure (mmHg) 131.21 ± 23.43
Diastolic blood pressure (mmHg) 81.57 ± 16.84
Microscopic hematuria (n/%) 67 (63.8 %)
Proteinuria(g/24 h) 2.04 ± 1.09
eGFR (mL/min/1.73 m2) 75.45 ± 39.18
Serum albumin (mg/dL) 33.88 ± 7.91
Serum total cholesterol (mg/dL) 5.76 ± 2.09
Serum IgA (mg/dL) 2.97 ± 1.92
Uric acid (mg/dL) 404.81 ± 123.59
Medical treatment (n/%)
 RAS blockers 83 (79 %)
 Immunosuppressant 38 (36.2 %)
  1. Data are presented as mean ± SD. eGFR, estimated glomerular filtration rate; IgAN, IgA nephropathy; RAS, renin-angiotensin system